Why is Remedium Life falling/rising?

As of 08-Sep, Remedium Lifecare Ltd's stock price is currently at 1.44, showing no change (0.00%). The stock has outperformed its sector today by 2.26%, and its performance over the past week has increased by 3.60%, while it has risen by 19.01% over the past month. However, the company has faced significant challenges, including a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt. The company has reported negative results for the last four consecutive quarters, with a drastic fall in net sales of -76.36%, and an annual operating profit growth rate of -303.30% over the last five years. These factors contribute to a negative outlook despite some short-term gains.
In the broader market context, the stock's short-term return of +3.60% over the past week significantly outpaces the Sensex, which has only increased by 0.53% in the same period. However, the stock has underperformed the market over the last year, with a staggering decline of -80.15% compared to the Sensex's slight drop of -0.49%. This stark contrast highlights the ongoing struggles of Remedium Lifecare Ltd, as it continues to face poor long-term growth prospects and negative EBITDA, making it a risky investment despite recent short-term performance improvements.